Medifast, Inc. Financials

Market Capitalization $160.2 Million as of July 1, 2025

Valuations Metrics as of May. 5, 2024

Trailing PE	4.31
Forward PE	14.12
Price to Sales TTM	$0.33
Price to Book MRQ	$1.35
Enterprise to Revenue	0.17
Enterprise to EBITDA	1.57

Financial Reports as of Mar. 31, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-03-31
Profit Margin	7.55%
Operating Margin	5.29%
Return on Assets TTM	16.44%
Return on Equity TTM	35.49%

Income Statement

Revenue TTM	$897,809,984
Revenue per Share TTM	$82.40
Quarterly Revenue Growth	-49.90%
Gross Profit TTM	$775,850,000
EBITDA	$94,225,000
Net Income to Common TTM	$67,763,000
Diluted EPS TTM	$6.19
Quarterly Earnings Growth YoY	-79.20%

Balance Sheet

Total Cash MRQ	$156,428,000
Total Cash per Share MRQ	$14.63
Total Debt MRQ	$
Total Debt to Equity MRQ	9.75
Current Ratio MRQ	2.85
Book Value per Share MRQ	$19.73

Cash Flow

Operating Cash Flow TTM	$90,880,000
Levered Free Cash Flow TTM	$56,581,876

MED Stock Info as of May. 5, 2024

Stock Statistics

Shares Outstanding	10,937,200
Float Shares	9,714,812
Avg 10 Volume	604,448
Avg 30 Volume	None
Shares Short	2,989,116
Short Ratio	6.79
Short % of Shares	41.43%
% Held by Insiders	2.69%
% Held by Institutions	96.24%

Stock Price Summary

Beta	1.15
Fifty Two Week Low	$25.36
Fifty Two Week High	$109.52
Fifty Two Week Change	-235.93%
Day 50 MA	$35.27
Day 200 MA	$63.42

Dividends and Splits

Forward Annual Dividend Rate	$6.60
Forward Annual Dividend Yield	24.73%
Trailing Annual Dividend Rate	$3.30
Trailing Annual Dividend Yield	12.36%
Payout Ratio	53.31%
Dividend Date	2023-11-07
Ex Dividend Date	2023-09-18
Last Split Factor
Last Split Date